Scientists hunt for genetic clues in rare lung syndrome
NCT ID NCT02439528
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 250 people to understand why some smokers develop a rare lung condition called combined pulmonary fibrosis and emphysema (CPFE). Researchers compared telomere length and genetic mutations in patients with CPFE, those with only fibrosis or emphysema, and healthy individuals. The goal was to find genetic differences that might explain why some people get this severe disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMBINED PULMONARY FIBROSIS AND EMPHYSEMA SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Albert Michallon, CHU de Grenoble
Grenoble, 38 043, France
-
Hôpital Nord, CHU de Saint-Etienne
Saint-Etienne, 42055, France
-
Hôpital pneumologique et cardiovasculaire Louis Pradel, HCL
Bron, 69677, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive tracer reveals the Body's journey of an experimental drug
- Can AI catch lung scarring that doctors might miss?
- Can music lessons rewire Teens' social media habits?
- Can a new pill slow lung scarring in IPF?
- Beyond the lungs: the hidden emotional toll of IPF medications
- Can umbilical cord stem cells ease a scarring lung disease?